Sei Investments Co. Lowers Stock Position in Walgreens Boots Alliance, Inc. (NASDAQ:WBA)

Sei Investments Co. decreased its holdings in shares of Walgreens Boots Alliance, Inc. (NASDAQ:WBA - Free Report) by 46.5% during the fourth quarter, according to the company in its most recent disclosure with the SEC. The fund owned 165,391 shares of the pharmacy operator's stock after selling 143,800 shares during the quarter. Sei Investments Co.'s holdings in Walgreens Boots Alliance were worth $1,543,000 at the end of the most recent reporting period.

Several other hedge funds and other institutional investors have also recently modified their holdings of the business. First Financial Corp IN increased its stake in Walgreens Boots Alliance by 49.2% in the 4th quarter. First Financial Corp IN now owns 2,685 shares of the pharmacy operator's stock worth $25,000 after buying an additional 885 shares during the period. Golden State Wealth Management LLC purchased a new position in shares of Walgreens Boots Alliance during the fourth quarter worth approximately $26,000. Riverview Trust Co increased its position in shares of Walgreens Boots Alliance by 123.8% during the fourth quarter. Riverview Trust Co now owns 2,874 shares of the pharmacy operator's stock worth $27,000 after acquiring an additional 1,590 shares during the period. Venturi Wealth Management LLC bought a new stake in shares of Walgreens Boots Alliance during the fourth quarter valued at approximately $28,000. Finally, TD Private Client Wealth LLC boosted its holdings in shares of Walgreens Boots Alliance by 8,670.3% in the third quarter. TD Private Client Wealth LLC now owns 3,245 shares of the pharmacy operator's stock valued at $29,000 after purchasing an additional 3,208 shares during the period. 58.59% of the stock is currently owned by hedge funds and other institutional investors.

Remove Ads

Walgreens Boots Alliance Stock Up 0.8 %

WBA stock traded up $0.09 on Friday, hitting $10.78. 12,267,104 shares of the company's stock were exchanged, compared to its average volume of 20,990,767. Walgreens Boots Alliance, Inc. has a 12-month low of $8.08 and a 12-month high of $18.83. The stock has a market cap of $9.32 billion, a P/E ratio of -1.05, a price-to-earnings-growth ratio of 1.31 and a beta of 0.67. The company has a debt-to-equity ratio of 0.68, a quick ratio of 0.30 and a current ratio of 0.64. The firm has a 50 day moving average price of $10.75 and a two-hundred day moving average price of $10.07.

Walgreens Boots Alliance (NASDAQ:WBA - Get Free Report) last posted its quarterly earnings results on Tuesday, April 8th. The pharmacy operator reported $0.63 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $0.53 by $0.10. Walgreens Boots Alliance had a negative net margin of 5.87% and a positive return on equity of 17.61%. The business had revenue of $38.59 billion during the quarter, compared to analysts' expectations of $37.90 billion. During the same quarter last year, the company posted $1.20 earnings per share. The business's quarterly revenue was up 4.1% on a year-over-year basis. As a group, equities research analysts expect that Walgreens Boots Alliance, Inc. will post 1.6 EPS for the current fiscal year.

Analyst Upgrades and Downgrades

Several research analysts have commented on WBA shares. Royal Bank of Canada raised their price objective on Walgreens Boots Alliance from $9.00 to $12.00 and gave the stock a "sector perform" rating in a report on Wednesday, January 15th. Bank of America lifted their price objective on Walgreens Boots Alliance from $7.50 to $8.50 and gave the company an "underperform" rating in a report on Monday, January 13th. Deutsche Bank Aktiengesellschaft lowered shares of Walgreens Boots Alliance from a "hold" rating to a "sell" rating and lowered their price objective for the stock from $11.00 to $9.00 in a research note on Friday, February 28th. Evercore ISI raised their target price on shares of Walgreens Boots Alliance from $9.00 to $12.00 and gave the company an "in-line" rating in a research report on Monday, January 13th. Finally, StockNews.com assumed coverage on shares of Walgreens Boots Alliance in a research report on Friday. They issued a "hold" rating for the company. Four equities research analysts have rated the stock with a sell rating, seven have issued a hold rating and two have given a buy rating to the stock. According to MarketBeat.com, the company presently has an average rating of "Hold" and an average price target of $10.59.

Walgreens Boots Alliance Company Profile

Walgreens Boots Alliance, Inc operates as a healthcare, pharmacy, and retail company in the United States, the United Kingdom, Germany, and internationally. It operates through three segments: U.S. Retail Pharmacy, International, and U.S. Healthcare. The U.S. Retail Pharmacy segment engages in operation of the retail drugstores, health and wellness services, specialty, and home delivery pharmacy services, which offers health and wellness, beauty, personal care and consumables, and general merchandise.